207 related articles for article (PubMed ID: 29414802)
1. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
2. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
3. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
[TBL] [Abstract][Full Text] [Related]
4. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
5. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus enhances cisplatin-induced hepatotoxicity via a mechanism involving suppression of glucose-regulated protein of 78 Kda.
Zhang X; Zhang R; Yang H; Xiang Q; Jiang Q; He Q; Zhang T; Chen C; Zhu H; Wang Q; Ning Q; Li Y; Lei P; Shen G
Chem Biol Interact; 2016 Jul; 254():45-53. PubMed ID: 27234046
[TBL] [Abstract][Full Text] [Related]
7. Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.
Zheng NQ; Zheng ZH; Xu HX; Huang MX; Peng XM
Virol J; 2017 Apr; 14(1):77. PubMed ID: 28407787
[TBL] [Abstract][Full Text] [Related]
8. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
9. Keratin 8 is involved in hepatitis B virus replication.
Zhong Q; An X; Yang YX; Hu HD; Ren H; Hu P
J Med Virol; 2014 Apr; 86(4):687-94. PubMed ID: 24375072
[TBL] [Abstract][Full Text] [Related]
10. High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial-mesenchymal transition.
Wang T; Jin Y; Zhao R; Wu Y; Zhang Y; Wu D; Kong D; Jin X; Zhang F
Int J Infect Dis; 2014 Mar; 20():37-41. PubMed ID: 24412602
[TBL] [Abstract][Full Text] [Related]
11. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells
Deng W; Chen F; Zhou Z; Huang Y; Lin J; Zhang F; Xiao G; Liu C; Liu C; Xu L
Front Mol Biosci; 2021; 8():745990. PubMed ID: 34805271
[No Abstract] [Full Text] [Related]
14. Short hairpin RNA induces methylation of hepatitis B virus covalently closed circular DNA in human hepatoma cells.
Park HK; Min BY; Kim NY; Jang ES; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Kim JW
Biochem Biophys Res Commun; 2013 Jun; 436(2):152-5. PubMed ID: 23727428
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
16. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
[TBL] [Abstract][Full Text] [Related]
17. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
18. [Role of glucose-6-phosphate dehydrogenase in hepatitis B virus replication and its possible mechanism of action].
Chen ZW; Guan YH; Ma LN; Liu XY; Yang YX; Hu HD; Ding XC; Hu P
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):347-51. PubMed ID: 27470887
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
[No Abstract] [Full Text] [Related]
20. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis.
Zhang Y; Li Y; Ma Y; Liu S; She Y; Zhao P; Jing M; Han T; Yan C; Wu Z; Gao J; Ye L
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G565-73. PubMed ID: 21719740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
